Near Death ExperienceNCT05544799
Case Studies of Patients Who Had Experienced Near Death Experience
An observational study of Near Death Experience, run by Seoul National University Hospital at 1 site in South Korea.
Trial summary
An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward. Read more about this study
- Who is it for?
- Ages 19 years and older
- Conditions the study is for
- Near Death Experience
- How many people
- 200 participants
- Where
- 1 siteSouth Korea
- Study dates
- 3 Jan 2021to 31 Dec 2031
- How long will I take part?
- 5 Years
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 19 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients with hematologic cancers who are in admission.
Who may be able to join
- Adult patients (≥19yrs) who are in admission in the Hematology ward of Seoul National University Hospital, and one of the following conditions.
- recovered after cardiopulomary resuscitation
- recovered after mechanical ventilator
- recovered after ICU care
- recovered after emergent operation
- recovered after Shock, coma, altered mentality
- Other medical conditions approaching death
Who cannot join
- Those who do not agree to participate this study
- Those who can not be interviewed due to insufficient recovery from critical medical problems
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
South Korea1 site, 1 recruiting
- Recruiting
Seoul National University Hospital
Seoul, 03080
Dong-Yeop Shin, M.D.
About this study
An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward.
- Conditions
- Near Death Experience
- Being tested
- No intervention
- Medical subject headings
- Death
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
No interventionOther
No intervension
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of near death experience (NDE)
Incidence of case with NDE scale ≥7 point
Measured: 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2022
- Study start3 Jan 2021
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Near Death ExperienceStudies of the same condition, open and under way.
- More trials run by Seoul National University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 200 participants (estimated)
- Target duration
- 5 Years
Sponsor and investigators
- Lead sponsor
- Seoul National University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dong-Yeop Shin, Seoul National University Hospital
- Investigators
- Dong-Yeop Shin, MD, PhD, Principal investigator, Department of Internal Medicine, Seoul National University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05544799
- Sponsor's protocol ID
- K-NDE
- Status last verified
- Jan 2026
- First submitted
- 14 Sep 2022
- Last updated
- 2 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Case Studies of Patients Who Had Experienced Near Death Experience
- ClinicalTrials.gov ID
- NCT05544799
- Acronym / sponsor ID
- K-NDE
- Conditions
- Near Death Experience
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Seoul National University HospitalUniversity, hospital or other
- Study start
- 3 Jan 2021 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2031 (estimated)
- First posted
- 16 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
An prospective observational study to interview patients who had near death experiences among those who had received intensive care unit intervention during admission in hematology ward.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 5 Years
Who may qualify
- Ages
- 19 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients with hematologic cancers who are in admission.
Key inclusion criteria (7 listed)
- Adult patients (≥19yrs) who are in admission in the Hematology ward of Seoul National University Hospital, and one of the following conditions.
Key exclusion criteria (2 listed)
- Those who do not agree to participate this study
- Those who can not be interviewed due to insufficient recovery from critical medical problems
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| No interventionNo intervension | Other | – |
Primary outcome
Incidence of near death experience (NDE)
Time frame: 5 years
Incidence of case with NDE scale ≥7 point
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Feb 2026.
- Individual participant dataSharing planned: No
Related trials for Near Death Experience
Not yet recruitingObservational study
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
Terminal Illness, End-of-Life Care
RecruitingObservational study
Episodes of (Dis)Connected Consciousness in ICU Survivors
Consciousness, Near Death Experience
RecruitingObservational study
Incidence of Episodes of (Dis)Connected Consciousness Among Emergency Patients Admitted in the Resuscitation Room
Critical Illness, Near-Death Experience
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Dong-Yeop Shin, MD, PhD principal investigator
Department of Internal Medicine, Seoul National University Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Near Death Experience, run by Seoul National University Hospital at 1 site in South Korea.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 2 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Dong-Yeop Shin, MD, PhD (+82220727209, stephano.dyshin@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of near death experience (NDE) (time frame: 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Feb 2026.